abstract |
Compounds of formula I inhibit PARP enzymes and are useful for the treatment of diseases or disorders associated with PARP. Also described are pharmaceutical compositions comprising a compound of formula I, a method of treatment comprising a compound of formula I and a method of inhibiting a PARP enzyme comprising a compound of formula I.n n n Formula I |